01 6Heartgard
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 372
2019 Revenue in Millions : 379
Growth (%) : -2
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 338
2020 Revenue in Millions : 372
Growth (%) : -2
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 350
2021 Revenue in Millions : 338
Growth (%) : 4
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 328
2022 Revenue in Millions : 350
Growth (%) : -5
Main Therapeutic Indication : Parasitic Infections
Currency : USD
2018 Revenue in Millions : 338
2017 Revenue in Millions : 321
Growth (%) : 5%
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 347
2018 Revenue in Millions : 326
Growth (%) : 6
LOOKING FOR A SUPPLIER?